↓ Skip to main content

Abstract OT1-03-02: Efficacy and safety of SKB264 for previously treated metastatic triple negative breast cancer in Phase 2 study

Overview of attention for article published in Cancer Research, March 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
1 Dimensions